SEC Form 4 · accession 0001659625-26-000011
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry O Gosebruch
Director
Period of report
Aug 19, 2026
Accepted (ET)
Aug 27, 2026 · 4:21 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 19, 2026 | A | 6,662 | $0.00 | A | 6,662 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a restricted stock award that will vest in three equal annual installments on the first, second and third anniversaries of August 19, 2026.